Myriad Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Myriad Asset Management's PFE Position: Q1 2022 in Review
Myriad Asset Management increased its Pfizer (PFE) stake by 19% in Q1 2022, buying an estimated $493K and bringing the position to 59,500 shares worth $3.08M. The position accounts for 0.43% of the portfolio, ranked #27.
Myriad Asset Management first reported a position in PFE in Q4 2021 and has held it in 2 quarters since. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Myriad Asset Management held 59,500 shares of Pfizer worth $3.08M as of Q1 2022.
- Myriad Asset Management bought 9,500 Pfizer shares in Q1 2022, an estimated $493K.
- Pfizer made up 0.43% of Myriad Asset Management's portfolio in Q1 2022, its #27 holding.
- Myriad Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 2 quarters since.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.